In Vitro Transcriptional Induction of the Human Apolipoprotein A-II Gene by Glucose

Diabetes

Volumn 53, Issue 3, 2004, Pages 672-678

  Sauvaget, Dominique ^a,b   Chauffeton, Valérie ^b   Dugué Pujol, Sonia ^a,b   Kalopissis, Athina Despina ^a,b   Guillet Deniau, Isabelle ^c   Foufelle, Fabienne ^a,b   Chambaz, Jean ^a,b   Leturque, Armelle ^a,b   Cardot, Philippe ^a,b   Ribeiro, Agnès ^a,b  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; LIVER CELL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEANING;

ANIMALS; APOLIPOPROTEIN A-II; BASE SEQUENCE; BLOOD GLUCOSE; DNA PRIMERS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LIVER; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 10744223846     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.3.672     Document Type: Article

References (46)

1. Evans M, Khan N, Rees A: Diabetic dyslipidaemia and coronary heart disease: new perspectives. Curr Opin Lipidol 10:387-391, 1999
2. Gordon DJ, Rifkind BM: High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 321:1311-1315, 1989
3. Sviridov D, Nestel P: Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161:245-254, 2002
4. Banka CL: High density lipoprotein and lipoprotein oxidation. Curr Opin Lipidol 7:139-142, 1996
5. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, et al.: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb 12:701-707, 1992
6. Blanco-Vaca F, Escola-Gil JC, Martin-Campos JM, Julve J: Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res 42:1727-1739, 2001
7. Kalopissis AD, Pastier D, Chambaz J: Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance. Curr Opin Lipidol 14:165-172, 2003
8. Boisfer E, Lambert G, Atger V, Tran NQ, Pastier D, Benetollo C, Trottier JF, Beaucamps I, Antonucci M, Laplaud M, Griglio S, Chambaz J, Kalopissis AD: Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J Biol Chem 274:11564-11572, 1999
9. Pastier D, Dugue S, Boisfer E, Atger V, Tran NQ, van Tol A, Chapman MJ, Chambaz J, Laplaud PM, Kalopissis AD: Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II. Biochemistry 40:12243-12253, 2001
10. Van't Hooft FM, Ruotolo G, Boquist S, deFaire U, Eggertsen G, Hamsten A: Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104:1223-1228, 2001
11. Vaulont S, Vasseur-Cognet M, Kahn A: Glucose regulation of gene transcription. J Biol Chem 275:31555-31558, 2000
12. Tu AY, Albers JJ: Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 50:1851-1856, 2001
13. Fournier N, Cogny A, Atger V, Pastier D, Goudouneche D, Nicoletti A, Moatti N, Chambaz J, Paul JL, Kalopissis AD: Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells. Arterioscler Thromb Vasc Biol 22:638-643, 2002
14. Guillet-Deniau I, Mieulet V, Le Lay S, Achouri Y, Carre D, Girard J, Foufelle F, Ferre P: Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51:1722-1728, 2002
15. Foretz M, Carling D, Guichard C, Ferre P, Foufelle F: AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem 273:14767-14771, 1998
16. Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P: Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem 274:1216-1225, 1999
17. Le Beyec J, Benetollo C, Chauffeton V, Domiar A, Lafrenière M-J, Chambaz J, Cardot P, Kalopissis AD: The -911/+29 sequnce of human apolipoprotein A-II promoter is sufficient to confer liver-restricted expression, developmental changes and response to a high-fat diet in transgenic mice. Transgenics 2:211-220, 1998
18. Chambaz J, Cardot P, Pastier D, Zannis VI, Cladaras C: Promoter elements and factors required for hepatic transcription of the human Apo A-II gene. J Biol Chem 266:11676-11685, 1991
19. Cardot P, Chambaz J, Kardassis D, Cladaras C, Zannis VI: Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription. Biochemistry 32:9080-9093, 1993
20. Hadzopoulou-Cladaras M, Kistanova E, Evagelopoulou C, Zeng S, Cladaras C, Ladias JAA: Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J Biol Chem 272:539-550, 1997
21. Staels B, Auwerx J, Chan L, van Tol A, Rosseneu M, Verhoeven G: Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine. J Lipid Res 30:1137-1145, 1989
22. Diaz Guerra MJ, Bergot MO, Martinez A, Cuif MH, Kahn A, Raymondjean M: Functional characterization of the L-type pyruvate kinase gene glucose response complex. Mol Cel Biol 13:7725-7733, 1993
23. Liu Z, Thompson KS, Towle HC: Carbohydrate regulation of the rat L-type pyruvate kinase gene requires two nuclear factors: LF-A1 and a member of the c-myc family. J Biol Chem 268:12787-12795, 1993
24. Ladias JA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis V, Cladaras C: Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem 267:15849-15860, 1992
25. Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ: Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler Thromb Vasc Biol 15:306-312, 1995
26. Ikewaki K, Zech LA, Brewer HB Jr, Rader DJ: Apo A-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apo A-II compared with the exogenous radiotracer method. J Lipid Res 37:399-407, 1996
27. Staels B, van Tol A, Chan L, Verhoeven G, Auwerx J: Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb 11:760-769, 1991
28. Lacorte JM, Fourniat E, Pastier D, Chambaz J, Ribeiro A, Cardot P: The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region. Biochem J 318:681-688, 1996
29. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21:1393-1403, 2001
30. Lehto M, Bitzen PO, Isomaa B, Wipemo C, Wessman Y, Forsblom C, Tuomi T, Taskinen MR, Groop L: Mutation in the HNF-4α gene affects insulin secretion and triglyceride metabolism. Diabetes 48:423-425, 1999
31. Shih DQ, Dansky HM, Fleisher M, Assmann G, Fajans SS, Stoffel M: Genotype/phenotype relationships in HNF-4α/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 49:832-837, 2000
32. Viollet B, Kahn A, Raymondjean M: Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol 17:4208-4219, 1997
33. Ktistaki E, Ktistakis NT, Papadogeorgaki E, Talianidis I: Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potential. Proc Natl Acad Sci U S A 92:9876-9880, 1995
34. Jiang G, Nepomuceno L, Yang Q, Sladek FM: Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch Biochem Biophys 340:1-9, 1997
35. Wang B, Cai SR, Gao C, Sladek FM, Ponder KP: Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver. Hepatology 34:979-989, 2001
36. Guo H, Wei J, Inoue Y, Gonzalez FJ, Kuo PC: Serine/threonine phosphorylation regulates HNF-4alpha-dependent redox-mediated iNOS expression in hepatocytes. Am J Physiol Cell Physiol 284:C1090-C1099, 2003
37. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, Carling D: Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20:6704-6711, 2000
38. Leclerc I, Lenzner C, Gourdon L, Vaulont S, Kahn A, Viollet B: Hepatocyte nuclear factor-4α involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50:1515-1521, 2001
39. Hong YH, Varanasi US, Yang W, Leff T: AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278:27495-27501, 2003
40. Escola-Gil JC, Marzal-Casacuberta A, Julve-Gil J, Ishida BY, Ordonez-Llanos J, Chan L, Gonzalez-Sastre F, Blanco-Vaca F: Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. J Lipid Res 39:457-462, 1998
41. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC: An autosomal genomic scan for loci linked to type 2 diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130-1138, 1998
42. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ: A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175-1182, 1999
43. Vionnet N, Hani EI-H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480, 2000
44. Elbein SC, Chu W, Ren Q, Wang H, Hemphill C, Hasstedt SJ: Evaluation of apolipoprotein A-II as a positional candidate gene for familial type 2 diabetes, altered lipid concentrations, and insulin resistance. Diabetologia 45:1026-1033, 2002
45. Castellani LW, Goto AM, Lusis AJ: Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 50:643-651, 2001
46. Weng W, Breslow JL: Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A 93:14788-14794, 1996